Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
O43286
UPID:
B4GT5_HUMAN
Alternative names:
Beta-1,4-GalT II; Glucosylceramide beta-1,4-galactosyltransferase; Lactosylceramide synthase; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5; UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5
Alternative UPACC:
O43286; E1P625; Q2M394; Q9UJQ8; U6C5D7
Background:
Beta-1,4-galactosyltransferase 5, known by alternative names such as Lactosylceramide synthase and UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5, plays a crucial role in the synthesis of lactosylceramide. This enzyme catalyzes the formation of LacCer from glucosylceramide, a key step in the biosynthesis of gangliosides, which are vital for neuronal maturation, axonal, and myelin formation in the CNS. Additionally, it is involved in the glycosylation of BMPR1A, affecting its stability, and is essential for early embryogenesis.
Therapeutic significance:
Understanding the role of Beta-1,4-galactosyltransferase 5 could open doors to potential therapeutic strategies, especially in neurological disorders and developmental anomalies.